NeuroBo Pharmaceuticals Welcomes Hyung Heon Kim as New CEO and President

Boston, MA, August 14, 2023 (PRNewswire) -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology firm dedicated to revolutionizing the landscape of cardiometabolic diseases, has unveiled the selection of its present Board member, Hyung Heon ("H.H.") Kim, as the newly instated Chief Executive Officer and President. In his new role, Mr. Kim takes the helm from Joseph Hooker, who assumed the position of interim Chief Executive Officer and President in January 2023.

Read full article here.